TABLE III.
Target organ | μSv/MBq | mrem/mCi |
---|---|---|
Adrenals | 3.3 | 12.2 |
Brain | 6.4 | 23.8 |
Breasts | 2.0 | 7.5 |
Gallbladder wall | 21.9 | 80.9 |
LLI wall | 2.2 | 8.2 |
Small intestine | 2.3 | 8.4 |
Stomach | 2.4 | 8.7 |
ULI wall | 2.4 | 8.8 |
Heart wall | 16.1 | 59.3 |
Kidneys | 13.0 | 48.1 |
Liver | 13.8 | 50.8 |
Lungs | 22.5 | 83.3 |
Muscle | 2.0 | 7.3 |
Ovaries | 2.3 | 8.4 |
Pancreas | 3.1 | 11.6 |
Red marrow | 2.0 | 7.4 |
Osteogenic cells | 2.6 | 9.6 |
Skin | 1.5 | 5.4 |
Spleen | 2.3 | 8.6 |
Tests | 1.7 | 6.4 |
Thymus | 2.5 | 9.2 |
Thyroid | 1.8 | 6.6 |
Urinary bladder wall | 26.0 | 96.0 |
Uterus body | 2.9 | 10.8 |
Total body | 2.8 | 10.4 |
Effective Dose Equivalent | 9.4 | 34.7 |
Effective Dose | 6.4 | 23.5 |
Dosimetry estimates are based on a 70-kg human male. Dynamic urinary bladder model was used with a 2.4 h voiding interval.